Free Trial

140 Summer Partners LP Acquires New Stake in UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • 140 Summer Partners LP acquired a new stake in UnitedHealth Group, purchasing 151,935 shares valued at approximately $79.58 million, making it the firm's third largest investment.
  • UnitedHealth reported earnings per share of $4.08 for the last quarter, falling short of the consensus estimate of $4.45, with a year-over-year revenue increase of 12.9%.
  • The company announced a quarterly dividend of $2.21 per share, translating to an annualized dividend yield of 2.9% and a payout ratio of 38.30%.
  • MarketBeat previews top five stocks to own in October.

140 Summer Partners LP bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 151,935 shares of the healthcare conglomerate's stock, valued at approximately $79,576,000. UnitedHealth Group accounts for about 10.2% of 140 Summer Partners LP's holdings, making the stock its 3rd largest holding.

Other hedge funds have also recently made changes to their positions in the company. Bayforest Capital Ltd grew its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its holdings in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Copia Wealth Management bought a new stake in UnitedHealth Group in the fourth quarter worth $42,000. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group in the first quarter worth $42,000. Finally, Investment Management Corp VA ADV bought a new stake in UnitedHealth Group in the fourth quarter worth $44,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $4.72 during trading on Friday, hitting $315.10. 14,093,579 shares of the company's stock were exchanged, compared to its average volume of 17,031,034. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The business's 50-day simple moving average is $288.78 and its 200 day simple moving average is $374.41. The company has a market cap of $285.38 billion, a price-to-earnings ratio of 13.65, a PEG ratio of 2.00 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group's payout ratio is 38.30%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on UNH shares. Barclays upped their price target on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Wolfe Research dropped their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, HSBC reissued a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $354.86.

Read Our Latest Stock Report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines